News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
539,878 Results
Type
Article (34045)
Company Profile (160)
Press Release (505673)
Multimedia
Podcasts (53)
Webinars (10)
Section
Business (155135)
Career Advice (801)
Deals (25280)
Drug Delivery (71)
Drug Development (59749)
Employer Resources (80)
FDA (14271)
Job Trends (11915)
News (259912)
Policy (24187)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2310)
Accelerated approval (4)
Adcomms (8)
Allergies (82)
Alliances (43511)
ALS (65)
Alzheimer's disease (1041)
Antibody-drug conjugate (ADC) (87)
Approvals (14316)
Artificial intelligence (253)
Autoimmune disease (14)
Automation (12)
Bankruptcy (211)
Best Places to Work (9761)
BIOSECURE Act (9)
Biosimilars (44)
Biotechnology (117)
Bladder cancer (50)
Brain cancer (22)
Breast cancer (214)
Cancer (1672)
Cardiovascular disease (129)
Career advice (712)
Career pathing (17)
CAR-T (126)
Cell therapy (333)
Cervical cancer (19)
Clinical research (49040)
Collaboration (716)
Compensation (207)
Complete response letters (11)
COVID-19 (2006)
CRISPR (38)
C-suite (197)
Cystic fibrosis (73)
Data (1708)
Decentralized trials (2)
Denatured (26)
Depression (32)
Diabetes (200)
Diagnostics (5820)
Digital health (17)
Diversity (7)
Diversity, equity & inclusion (18)
Drug discovery (100)
Drug pricing (63)
Drug shortages (23)
Duchenne muscular dystrophy (63)
Earnings (54864)
Editorial (22)
Employer branding (12)
Employer resources (71)
Events (76883)
Executive appointments (579)
FDA (15347)
Featured Employer (35)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (590)
Gene editing (93)
Generative AI (25)
Gene therapy (223)
GLP-1 (512)
Government (3456)
Grass and pollen (4)
Guidances (43)
Healthcare (15593)
Huntington's disease (12)
IgA nephropathy (19)
Immunology and inflammation (52)
Indications (21)
Infectious disease (2114)
Inflammatory bowel disease (103)
Inflation Reduction Act (5)
Influenza (42)
Intellectual property (75)
Interviews (101)
IPO (10936)
IRA (23)
Job creations (2566)
Job search strategy (621)
Kidney cancer (7)
Labor market (15)
Layoffs (247)
Leadership (7)
Legal (4961)
Liver cancer (60)
Lung cancer (249)
Lymphoma (106)
Machine learning (4)
Management (29)
Manufacturing (211)
MASH (51)
Medical device (14025)
Medtech (14030)
Mergers & acquisitions (14756)
Metabolic disorders (496)
Multiple sclerosis (60)
NASH (12)
Neurodegenerative disease (61)
Neuropsychiatric disorders (11)
Neuroscience (1424)
NextGen: Class of 2025 (5419)
Non-profit (3431)
Northern California (1789)
Now hiring (20)
Obesity (247)
Opinion (130)
Ovarian cancer (62)
Pain (75)
Pancreatic cancer (66)
Parkinson's disease (111)
Partnered (16)
Patents (183)
Patient recruitment (85)
Peanut (47)
People (47554)
Pharmaceutical (32)
Pharmacy benefit managers (12)
Phase I (15164)
Phase II (21426)
Phase III (16557)
Pipeline (849)
Policy (75)
Postmarket research (1811)
Preclinical (5897)
Press Release (67)
Prostate cancer (81)
Psychedelics (18)
Radiopharmaceuticals (213)
Rare diseases (249)
Real estate (4630)
Recruiting (30)
Regulatory (17398)
Reports (18)
Research institute (2083)
Resumes & cover letters (114)
Rett syndrome (4)
RNA editing (2)
RSV (32)
Schizophrenia (51)
Series A (101)
Series B (65)
Service/supplier (8)
Sickle cell disease (32)
Southern California (1639)
Special edition (6)
Spinal muscular atrophy (118)
Sponsored (21)
Startups (3208)
State (2)
Stomach cancer (9)
Supply chain (47)
Tariffs (8)
The Weekly (26)
United States (16945)
Vaccines (522)
Venture capitalists (25)
Weight loss (159)
Women's health (25)
Worklife (6)
Date
Last 7 days (376)
Last 30 days (1657)
Last 365 days (25772)
2025 (7159)
2024 (27777)
2023 (31935)
2022 (42322)
2021 (45784)
2020 (44600)
2019 (39176)
2018 (29799)
2017 (26823)
2016 (25763)
2015 (30045)
2014 (22832)
2013 (19214)
2012 (20808)
2011 (21296)
2010 (19659)
Location
Africa (526)
Alabama (46)
Alaska (7)
Arizona (174)
Arkansas (13)
Asia (33809)
Australia (5729)
California (4234)
Canada (1610)
China (427)
Colorado (198)
Connecticut (222)
Delaware (117)
Europe (71523)
Florida (700)
Georgia (177)
Idaho (48)
Illinois (427)
India (18)
Indiana (253)
Iowa (5)
Japan (143)
Kansas (100)
Kentucky (15)
Louisiana (6)
Maine (33)
Maryland (741)
Massachusetts (3003)
Michigan (218)
Minnesota (313)
Mississippi (2)
Missouri (71)
Montana (27)
Nebraska (23)
Nevada (38)
New Hampshire (66)
New Jersey (1369)
New Mexico (20)
New York (1269)
North Carolina (761)
North Dakota (8)
Northern California (1789)
Ohio (165)
Oklahoma (11)
Oregon (30)
Pennsylvania (972)
Puerto Rico (11)
Rhode Island (29)
South America (777)
South Carolina (21)
South Dakota (1)
Southern California (1639)
Tennessee (83)
Texas (666)
Utah (152)
Virginia (95)
Washington D.C. (41)
Washington State (430)
West Virginia (3)
Wisconsin (50)
539,878 Results for "shine medical technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Baird Medical Shines at 2025 Microcap Conference: Driving Growth Through Technological Innovation and Strategic Collaborations
January 30, 2025
·
4 min read
Press Releases
Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology Following SHINE Prediabetes Study Success
March 10, 2025
·
2 min read
Business
SHINE Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility
SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics, a Bracco company and recognized leader in the development of innovative radiopharmaceuticals.
June 6, 2024
·
3 min read
Press Releases
Shining a spotlight on the Montreal Chest Institute
February 28, 2025
·
5 min read
Press Releases
Ractigen’s RAG-17 ALS Data Shines at AAN 2025: Earns Top Award, Phase I Advances
April 9, 2025
·
5 min read
BioMidwest
SHINE Technologies to Exhibit at 7th Annual Theranostics World Congress
SHINE Technologies will showcase its innovative capabilities for producing non-carrier-added lutetium-177 (n.c.a Lu-177), a radioisotope used in targeted cancer treatments, at the 7th Theranostic World Congress (TWC), March 22-24 in Santiago, Chile.
March 18, 2024
·
2 min read
Policy
SHINE Technologies, LLC Announces Submission of FDA Drug Master File for Non-Carrier-Added Lutetium-177
SHINE Technologies, LLC, a pioneer in next-generation fusion-based technology, becomes North America’s largest producer of non-carrier added lutetium-177 chloride, a cutting-edge radiopharmaceutical used in precision cancer treatment, with a Drug Master File to the U.S. Food and Drug Administration.
April 8, 2024
·
3 min read
Press Releases
GlyTherix to Partner with SHINE Technologies for Advancing Targeted Radiotherapy in Aggressive Cancers
September 18, 2024
·
4 min read
Business
SHINE Technologies and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatments
SHINE Technologies today announced a long-term supply agreement with Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals.
November 16, 2023
·
4 min read
Press Releases
SHINE Technologies Collaborates with University of Wisconsin-Madison and WARF Therapeutics to Create Promising New Treatments for Kidney and Prostate Cancers
October 18, 2024
·
7 min read
1 of 53,988
Next
